← Back to Search

3D Ultrasound Imaging for Breast Cancer Detection

N/A
Recruiting
Led By Shigao Chen, Ph.D.
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adult women, ≥ 18 years of age.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights

Study Summary

This trial will test how well a new ultrasound imaging method can detect breast masses.

Who is the study for?
This trial is for adult women over 18 with a breast lesion who are scheduled for a biopsy. It's not open to those under 18, anyone with previous breast surgery or implants, those unable to consent, pregnant or breastfeeding women, or patients currently undergoing cancer treatments.Check my eligibility
What is being tested?
The study is testing the effectiveness of a new ultrasound imaging method using two different scanners: the GE Logiq E10 and the Verasonics research scanner. The goal is to see how well they diagnose breast masses compared to current methods.See study design
What are the potential side effects?
Ultrasound scanning is generally safe and does not have significant side effects. However, there might be minor discomfort due to pressure from the ultrasound probe during imaging.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a woman aged 18 or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
BI-RADS Score

Trial Design

1Treatment groups
Experimental Treatment
Group I: Clinically indicated breast tumor biopsyExperimental Treatment2 Interventions
Subjects with breast lesion and are scheduled for clinically-indicated biopsy will have 3D Multimodal Ultrasound Imaging performed

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,207 Previous Clinical Trials
3,767,015 Total Patients Enrolled
83 Trials studying Breast Cancer
13,912 Patients Enrolled for Breast Cancer
United States Department of DefenseFED
863 Previous Clinical Trials
227,507 Total Patients Enrolled
37 Trials studying Breast Cancer
3,466 Patients Enrolled for Breast Cancer
Shigao Chen, Ph.D.Principal InvestigatorMayo Clinic
1 Previous Clinical Trials
50 Total Patients Enrolled

Media Library

GE Logiq E10 clinical ultrasound scanner Clinical Trial Eligibility Overview. Trial Name: NCT04692818 — N/A
Breast Cancer Research Study Groups: Clinically indicated breast tumor biopsy
Breast Cancer Clinical Trial 2023: GE Logiq E10 clinical ultrasound scanner Highlights & Side Effects. Trial Name: NCT04692818 — N/A
GE Logiq E10 clinical ultrasound scanner 2023 Treatment Timeline for Medical Study. Trial Name: NCT04692818 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still opportunities to enroll in this research project?

"Affirmative. The clinical trial information on the website verifies that recruitment is taking place for this experiment, which was initially posted in November 2021 and recently revised in December of the same year. 125 patients are being sought from a single site."

Answered by AI

What is the current cohort size for this research endeavor?

"Affirmative. The clinicaltrials.gov website states that this experiment is currently seeking participants, which was initially posted on November 19th 2021 and last modified on December 23rd 2021. 125 volunteers are required from 1 site for the trial to proceed."

Answered by AI
~27 spots leftby Dec 2024